Social Media Ideas for #Chikungunyavaccine

1st dengue vaccine gets DCGI nod, set to hit market next year

Takeda aims for dengue vaccine inclusion in India's shots program

India approves its first dengue vaccine, from Japan's Takeda

Chikungunya: Η νέα… εξωτική απειλή που έφεραν τα κουνούπια

Δεκάδες κρούσματα του ιού έχουν καταγραφεί στη Γαλλία, ενώ παράλληλα έχουν εντοπιστεί πέντε κρούσματα δάγκειου πυρετού

Takeda’s QDENGA approved in India, can be given despite pre-exposure to dengue

It is India’s first dengue vaccine approved for use in individuals regardless of prior exposure, without pre-vaccination testing, the multinational healthcare company stated

CDC issues travel notice for tropical hotspot as outbreak of deadly incurable mosquito virus reaches Americas

According to a report from the Daily Mail, the U.S. Centers for Disease Control and Prevention (CDC) has issued a Level 2 travel advisory for Costa Rica due to an active outbreak o...

New Zika Virus Vaccine Approach Harnesses the Power of T Cells in Mice

An experimental Zika vaccine protected mice through CD8+ T cells, suggesting a possible path around antibody-dependent enhancement concerns that have complicated vaccine developmen...

Ahead of dengue vaccine rollout, all 4 strains found in circulation

India's first dengue virus mapping shows all four serotypes circulating in eight states. This finding could influence the country's upcoming dengue vaccine strategy. Researchers...

Malaria Mosquito Bites Turned Into Immune Boosters in New Chemovaccination Strategy

A malaria chemovaccination strategy, using antimalarial compounds to arrest parasites in the liver, turns mosquito bites into immune-boosting vaccination events that protected mice...

Chikungunya and dengue fever reported in south-west France

Cases of the tropical diseases of chikungunya and dengue fever have been reported in south-west France, including Dordogne, thought to be spread by tiger mosquitoes.

New study finds hexavalent vaccine could make India's immunization program more efficient and family-friendly

A study appearing in Human Vaccines & Immunotherapeutics found that introducing the hexavalent (six-in-one) vaccine into India's Universal Immunization Program (UIP) could impr...

Care Health Insurance Issues Public Health Advisory on Mosquito-Borne Diseases

National, August 19, 2026: With monsoon increasing the risk of mosquito-borne diseases such as dengue, malaria, and chikungunya, Care Health Insurance has issued a… The post Care H...

CEPI-backed Ebola vaccine set to enter phase 1 trials

The first vaccine against the Bundibugyo ebola virus is poised to enter phase 1 clinical trial.

Ebola virus: first person vaccinated in UK trial of new jab

A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic...

Personalized Vaccine Helped Melanoma Patients Stay Cancer-Free Longer, Drugmakers Say

THURSDAY, Aug. 20, 2026 — An experimental vaccine kept melanoma from returning or spreading in people at high risk of the skin cancer coming back, drugmakers Moderna and Merck anno...

Viral Outbreak Prompts CDC Travel Advisory for Costa Rica

By Jack Phillips Federal officials this week issued a travel advisory for Costa Rica due to an outbreak of the mosquito-borne chikungunya virus. Meanwhile, the U.S. Embassy for Cos...

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugy...

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of...

Dengue fever mosquito borne infection: Dr Ajaz Ahmad

Design of an immunogen containing multidimensionally conserved and immunogenic parts of the HIV proteome

by Eric Wang, Arup K. Chakraborty Despite decades of research, an effective HIV vaccine or cure has not yet been developed. An important reason is the virus’s mutability, which al...

Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolav...

L'essai de phase 1 évaluera l'innocuité et la réponse immunitaire pour une souche de la maladie à virus Ebola pour laquelle aucun vaccin n'est actuellement autoriséL'essai de phase...

Adjuvant duo CpG 1018 and alum supercharges N2 flu vaccine immunity

Two Classic Adjuvants, One Powerful Punch: CpG 1018 and Alum Supercharge Immunity to an N2 Neuraminidase Flu Vaccine For nearly a century, influenza vaccine design has been a love...

Africa: Biovac's Cholera Vaccine Test for Africa's Self-Reliance

[Independent (Kampala)] The continental bid to make more of its own vaccines is moving from ambition to production

Historic Ebola Virus vaccine testing begins in Oxford

Scientists at the Oxford Vaccine Group (OVG) inoculated the first volunteer with a new vaccine against Bundibugyo ebolavirus (BDBV) on 24 July. The milestone comes after just weeks...

Volunteer In U.K. Receives First Experimental Ebola Vaccine As Congo Cases Rise

The deadly Bundibugyo ebolavirus strain currently has no licensed vaccine or specific treatments and is spreading faster than all previous Ebola outbreaks.